EIDD-1931

SKU: orb1298882

Description

EIDD-1931 is a ribonucleoside analog exhibiting broad-spectrum antiviral activity against betacoronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2, with low micromolar IC50 values in vitro. Its research applications extend to studying viral replication mechanisms and evaluating antiviral efficacy in both cellular and animal models of coronavirus infection.

Research Area

Infectious Disease & Virology, Molecular Biology, Protein Biochemistry

Key Properties

• CAS Number: 3258-02-4
• MW: 259.22
• Purity: 99.18%
• Formula: C₉H₁₃N₃O₆
• SMILES: OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc\c(=N/O)[nH]c1=O
• Target: Virus Protease,SARS-CoV,HCV Protease,Topoisomerase
• Solubility: DMSO:255 mg/mL (983.72 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.72 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Topoisomerase, Rhinovirus, SARS coronavirus, SARSCoV, SARS-CoV, β-d-N4-hydroxycytidine, Virus Protease, VirusProtease, venezuelan, NHC, inhibit, Inhibitor, equine, EIDD 1931, EIDD1931, EIDD-1931, encephalitis, Enterovirus, Enterovirus,VEEV, HCVProtease, HCV, HCV Protease, Hepatitis C virus, HEV, HEVs, HRVs, HRV, CHIKV, Beta-d-N4-hydroxycytidine, Chikungunya, b-d-N4-hydroxycytidine

Compound Identifiers

PubChem CID

197020